If you’ve got $6,000 in TFSA (Tax-Free Savings Account) cash to invest for the long term, you’ve come to the right place. Investors are rattled over rising U.S. bond yields, which has spelled bad news for tech stocks, especially the high-flying ones that are not yet profitable. In this piece, we’ll look at three value names that appear too cheap for their own good.
IA Financial: A well-run insurer at a bargain-basement price
IA Financial is a cheap Canadian insurance and non-bank wealth manager that ought to be scooped up here. The stock surged 72% off its March 2020 depths but remains the name still remains too cheap to ignore, given the calibre of business you’re getting. The stock sports a bountiful 3% yield, which, while lower than its Canadian insurance peers, is well covered, with more room to run over the next five years and beyond.
At the time of writing, the stock trades at 0.4 times sales, 3.8 times cash flow, and 1.1 times book value, all of which are still lower than the stock’s five-year historical average multiples of 0.5, 11.6, and 1.2, respectively.
Bausch Health Companies: Activist investor Carl Icahn’s involvement could propel shares in a post-COVID environment
Bausch Health Companies is a Canadian biopharmaceutical company with a brilliant management team. Led by CEO Joe Papa, the company has moved on from its days as the infamous Valeant Pharmaceuticals and its debt-fueled acquisition spree.
Papa has done a terrific job of trimming away at the mountain of debt while injecting cash into innovative health solutions. And with activist investor Carl Icahn jumping on board to help enhance shareholder value, I think investors should think strongly about loading up on shares on any meaningful dips.
The stock is still modestly-valued at 1.44 times sales and 7.2 times next year’s expected earnings.
Spin Master: Canadian toymaker comes roaring back
Spin Master made headlines last week, with the company reporting much better-than-expected earnings that sent shares soaring over 44%.
The company made major strides in the fourth quarter, solving serious supply chain issues that weighted down its prior quarters. The company saw its pretty flat net sales, with revenues inching up just under 4%. Adjusted EPS numbers were at $0.14, doubling that of consensus estimates calling for $0.07. The biggest takeaway from the quarter, I thought, was the profound strength in the digital game revenues, which skyrocketed over 400% to US$31.8 million.
Optimistic management expectations also provided rally fuel for the stock, and it may very well just be a preview of what’s the come as “the roaring 2020s” look to take hold over the next five years. In any case, the stock remains way too cheap here after its blowout quarter. The stock trades at a mere two times sales at the time of writing.
Sell-side analysts hiked their price targets after the fact. Most recently, RBC Capital Markets hiked its rating on Spin Master from sector perform to outperform, with a massive $10 upgrade to $44, representing another 25% worth of upside from today’s levels.
Speaking of incredible value, check out these Foolish top picks from our team here at The Motley Fool!
Motley Fool Canada's market-beating team has just released a brand-new FREE report revealing 5 "dirt cheap" stocks that you can buy today for under $49 a share.
Our team thinks these 5 stocks are critically undervalued, but more importantly, could potentially make Canadian investors who act quickly a fortune.
Don't miss out! Simply click the link below to grab your free copy and discover all 5 of these stocks now.
This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.
Fool contributor Joey Frenette has no position in any of the stocks mentioned. Tom Gardner owns shares of Bausch Health Companies. The Motley Fool owns shares of and recommends Bausch Health Companies and Spin Master.